EyePoint Pharmaceuticals: is This a Share to Keep your Eye on?
EYPT

EyePoint Pharmaceuticals, Inc. ($EYPT) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. Recent developments equals happy investors? A little month ago, its share rose with 35% on the premarket after expanding its…

New Preclinical Results Are Encouraging: How Much Can Vaxart Climb?
VXRT

Vaxart, Inc. ($VXRT) – a well-known clinical stage biotechnology company developing oral recombinant vaccines that are administered via tablets rather than injections – is breaking the news this morning. The COVID-19 vaccine candidate has shown encouraging results in preclinical research. Vaxart is now announcing a pre-publication of a manuscript on this matter named: “Preclinical Studies…